Yuzhen Feng & colleagues at the University of Groningen found that #HPV uses a specific interaction with cell surface molecules to change its structure, making it easier to infect cells. This discovery could lead to improved prevention methods Read the paper 👉 bit.ly/3P5Wd3d #IPVSPaperOfTheWeek #cancerprevention #HPVdiseases
INTERNATIONAL PAPILLOMAVIRUS SOCIETY - IPVS’ Post
More Relevant Posts
-
New in Science Magazine from Drs. Nish Reddy, Wendell Lim, and others at the University of California, San Francisco! They engineered human T cells to make a synthetic receptor that can recognize overactive T cells, such as those that cause #autoimmune disease and organ rejection. 📃: https://bit.ly/3ZLzWwA 🎧: https://bit.ly/3DmtYKX
-
-
New in JBC press: "Scientists' results suggest a new mode of regulatory control of mitochondrial energetics through modulation of FOXK2 cellular abundance." Learn more: https://lnkd.in/eiE8t8es
-
-
New in JBC press: "Scientists' results suggest a new mode of regulatory control of mitochondrial energetics through modulation of FOXK2 cellular abundance." Learn more: https://lnkd.in/eiE8t8es
-
-
Multicenter study of long-term outcome of resection of para-aortic lymph-node metastasis of CRC. Does this have a significant effect on survival? Read more in this month's #DCRJournal: https://bit.ly/4hcaCYu
-
-
Of the 480,000 preemies born in the US each year, 9,000 are affected by necrotizing enterocolitis (NEC). One-third of those affected don't survive. LSU Health Sciences Center New Orleans genetics professor Sunyoung Kim, PhD recently received a patent for a test that doubles the accuracy of an NEC diagnosis. This noninvasive test allows for earlier intervention, helping medical professionals prevent the severe complications associated with NEC. Learn more: https://lnkd.in/gwB84nNX #ScholarshipFirst
-
-
You can read the new study published by me and my colleague entitled "Navigating the complexities of cell death: Insights into accidental and programmed cell death" from the link below. In this study, we introduced different types of cell death. link: https://lnkd.in/ehdsmkAr
-
-
#ICYMI: Our scientists recently sat down to discuss the NLRP3 inflammasome and how the functions of NLRP3 and NEK7 are closely linked. Learn more about the NLRP3/NEK7 connection and Monte Rosa’s innovative work with a NEK7-directed molecular glue degrader targeting this important pathway. Full video here: https://bit.ly/3yCAvPn #MGDs #NLRP3 #NEK7
Interest in the NLRP3 inflammasome is surging, as the pathway is implicated in a number of inflammatory disorders. Magnus Walter, Senior Vice President of Drug Discovery, and Alison Paterson, Vice President of Biology, recently sat down to discuss the critical role NEK7 plays in activating the NLRP3 inflammasome. Monte Rosa’s groundbreaking work with a NEK7-directed molecular glue degrader offers a promising new approach to target this pathway. Don't miss this insightful conversation and find the full video here: https://bit.ly/3yCAvPn #MGDs #NLRP3 #drugdiscovery
-
On #WorldStrokeDay, we are proud to spotlight the groundbreaking EU Horizon research project ANGIE_h2020, which has developed innovative dissolvable microrobots for targeted drug delivery in the treatment of ischemic stroke (strokes caused by blood clots that block blood flow to the brain). Led by Principal Investigator Professor Salvador Panè, this technology could revolutionize stroke care by delivering treatment directly to blood clots, reducing side effects and improving recovery outcomes. Professor Panè calls this a “significant leap forward,” while Arlene Wilkie from Stroke Alliance for Europe looks forward to its impact on urgent stroke care in the future. Learn more here 👉 https://bit.ly/3Aj1cK6 #StrokeResearch #ClinicalTrials #StrokeInnovation
-
The aim of this study was to develop a #DeepLearning model in order to improve the diagnostic performance of EIC and ASPECTS in acute ischemic stroke, resulting in a better performance from radiologists when assisted by the model. (Weidao Chen et al.) #InsightsIntoImaging 🔗 https://buff.ly/4a2jY4b
-
